|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,583,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,917,000 |
Avg
Vol: |
900,954 |
52
Week Range: |
$259.55 - $259.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Duggan Robert W |
Chairman and CEO |
|
2012-12-27 |
5 |
D |
$0.00 |
$0 |
I/I |
(125,000) |
376,119 |
|
- |
|
Van Den Broek Richard |
Director |
|
2012-12-27 |
4 |
S |
$58.02 |
$692,239 |
I/I |
(11,931) |
126,799 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2012-12-27 |
4 |
S |
$59.00 |
$763,725 |
D/D |
(12,900) |
22,992 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2012-12-27 |
4 |
OE |
$4.47 |
$77,883 |
D/D |
12,900 |
35,892 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2012-12-26 |
4 |
S |
$59.00 |
$5,900 |
D/D |
(100) |
22,992 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2012-12-26 |
4 |
OE |
$4.47 |
$447 |
D/D |
100 |
23,092 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2012-12-24 |
5 |
D |
$0.00 |
$0 |
I/I |
(995) |
501,119 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2012-12-24 |
5 |
GA |
$0.00 |
$0 |
I/I |
128,628 |
21,438 |
|
- |
|
Duggan Robert W |
Chairman and CEO |
|
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
150,066 |
13,300,292 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,000 |
9,485 |
|
- |
|
Loury David J |
Chief Scientific Officer |
|
2012-12-20 |
4 |
S |
$61.12 |
$2,412,274 |
D/D |
(39,469) |
325 |
|
- |
|
Loury David J |
Chief Scientific Officer |
|
2012-12-20 |
4 |
OE |
$4.16 |
$164,191 |
D/D |
39,469 |
39,794 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-12-18 |
4 |
S |
$62.41 |
$3,721,092 |
D/D |
(59,558) |
27,485 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-12-18 |
4 |
OE |
$0.91 |
$54,198 |
D/D |
59,558 |
87,043 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-12-17 |
4 |
S |
$62.73 |
$2,160,698 |
D/D |
(34,442) |
27,485 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-12-17 |
4 |
OE |
$0.91 |
$31,342 |
D/D |
34,442 |
61,927 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2012-12-17 |
4 |
S |
$62.14 |
$3,106,840 |
D/D |
(50,000) |
6,701 |
|
- |
|
Buggy Joseph J |
VP, Research |
|
2012-12-17 |
4 |
OE |
$0.75 |
$37,500 |
D/D |
50,000 |
56,701 |
|
- |
|
Hemmi Gregory |
VP Chemical Operations |
|
2012-10-31 |
4 |
A |
$10.56 |
$7,242 |
D/D |
686 |
22,992 |
|
- |
|
Huh Christine |
VP, Human Resources |
|
2012-10-31 |
4 |
A |
$23.07 |
$21,247 |
D/D |
921 |
4,921 |
|
- |
|
Fardis Maria |
EVP, Operations and Alliances |
|
2012-10-31 |
4 |
A |
$10.56 |
$3,452 |
D/D |
327 |
3,476 |
|
- |
|
Mcgreivy Jesse |
VP, Clinical Science |
|
2012-10-31 |
4 |
A |
$23.07 |
$13,449 |
D/D |
583 |
583 |
|
- |
|
Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
|
2012-10-31 |
4 |
A |
$23.07 |
$18,870 |
D/D |
818 |
818 |
|
- |
|
Loury David J |
Chief Scientific Officer |
|
2012-10-31 |
4 |
A |
$10.56 |
$1,721 |
D/D |
163 |
325 |
|
- |
|
Erdtmann Rainer M |
VP, IR Education Training |
|
2012-10-31 |
4 |
A |
$10.56 |
$15,170 |
D/D |
1,437 |
27,485 |
|
- |
|
355 Records found
|
|
Page 6 of 15 |
|
|